id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2020-0003-0010,DEA,DEA-2020-0003,Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V,Rule,,2021-05-24T04:00:00Z,2021,5,2021-05-24T04:00:00Z,,2021-05-25T15:49:44Z,2021-10827,0,0,0900006484b2e413
DEA-2020-0003-0001,DEA,DEA-2020-0003,Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V,Rule,,2020-01-31T05:00:00Z,2020,1,2020-01-31T05:00:00Z,2020-03-03T04:59:59Z,2021-05-25T15:40:37Z,2020-01957,0,0,0900006484316555